Brentwood, Tenn.-based Ardent Health has a new president and CEO, but the publicly traded for-profit system’s three-pronged growth strategy remains unchanged.
Ardent will continue to focus on strengthening EBITDA margins, accelerating growth in core markets and pursuing disciplined mergers and acquisitions, but with “sharper operational execution,” Dave Caspers told investors on the system’s Aug. 5 earnings call.
“We will continue to manage through the healthcare head and tailwinds, but as an operator, I am laser focused on the performance that we can directly influence: how we staff, how we contract, how we allocate capital, how we standardize and how we hold ourselves accountable,” Mr. Caspers said on the call.
Mr. Caspers took the reins as president and CEO on June 2, succeeding Marty Bonick, who stepped down to pursue other opportunities after serving as CEO since 2020. Mr. Caspers joined Ardent as COO in March 2025. He previously served as Walmart Health’s vice president of omnichannel operations. He also brings experience from Phoenix-based Banner Health, where he held various leadership roles, including serving as vice president of healthcare operations.
As part of the sharpened focus on execution, Mr. Caspers said Ardent is building a culture that works as one team, aligned around one plan and delivering with one standard.
“I see additional opportunity to reduce variation and strengthen consistency in our execution. As such, I am keenly focused on the executive-level KPI-driven decision making, reducing unwanted variation and strengthening our accountability,” he said.
A key priority is carrying forward the momentum of Project Impact, Ardent’s multi-year cost-savings and performance-improvement initiative.
Ardent has raised its 2026 Project Impact savings target twice this year: from $40 million originally, to $55 million when the company reported fourth-quarter 2025 earnings, to more than $70 million now. Two moves account for most of the latest increase. The system’s June payer contract renewal in one market is expected to add $5 million to $10 million to 2026 adjusted EBITDA. A restructuring that cut managerial layers at both the corporate and field level is expected to generate $15 million to $20 million in savings this year, with a full annualized impact of $30 million to $35 million.
“We will continue to evaluate our portfolio and take action where we see opportunities to sharpen our focus and improve our margins,” Mr. Caspers said. “That will entail assessing and evaluating all aspects of our operations, and if an asset or service line is not the right long-term fit, we will act thoughtfully and with discipline.”
As an example, Mr. Caspers pointed to the system’s intentional service line rationalization work in the second quarter. Ardent moved lower-margin procedures, including ENT and ophthalmology, out of the hospital setting to free up capacity for higher-margin service lines.
Mr. Caspers said that same discipline will define his leadership going forward.
“We will push Ardent to be more nimble and faster while maintaining our strong commitment to patient care, quality, and safety,” he said. “We will measure what matters, focus on fewer but more important priorities, and pivot quickly as necessary when circumstances change.”
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.
